Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 24381959400

Activities

Collapse all

Employment (3)

University of Colorado Denver: Aurora, CO, US

2016-08-01 to present | Assistant Professor (Pathology)
Employment
Source: Self-asserted source
Matthew J. Sikora

University of Pittsburgh: Pittsburgh, PA, US

2015-04-01 to 2016-07-31 | Research Instructor (Pharmacology & Chemical Biology)
Employment
Source: Self-asserted source
Matthew J. Sikora

University of Pittsburgh: Pittsburgh, PA, US

2011-07-01 to 2015-03-31 | Postdoctoral Associate (Pharmacology & Chemical Biology)
Employment
Source: Self-asserted source
Matthew J. Sikora

Education and qualifications (3)

University of Pittsburgh: Pittsburgh, PA, US

2011-07-01 to 2015-03-31 | Postdoctoral Associate (Pharmacology & Chemical Biology)
Education
Source: Self-asserted source
Matthew J. Sikora

University of Michigan Medical School: Ann Arbor, MI, US

2006-09-01 to 2011-05-01 | Ph.D. (Pharmacology)
Education
Source: Self-asserted source
Matthew J. Sikora

University of Michigan: Ann Arbor, MI, US

2002-09-01 to 2006-05-01 | B.S. (Genetics and Molecular Biology)
Education
Source: Self-asserted source
Matthew J. Sikora

Funding (8)

Novel roles of MDC1 in endocrine response and resistance in breast cancer

2020-09-01 to 2025-02-28 | Grant
American Cancer Society (Atlanta, US)
DOI: 10.53354/ACS.RSG-20-042-01-DMC.pc.gr.92447
GRANT_NUMBER:

RSG-20-042-01-DMC
Source: check_circle
American Cancer Society - ProposalCentral

Defining MDC1 as a central regulator of estrogen receptor and DNA repair in lobular carcinoma

2019-07 to 2020-06 | Award
Cancer League of Colorado (CO, CO, US)
GRANT_NUMBER:

193324-MS

Source: Self-asserted source
Matthew J. Sikora

Exploiting apoptotic vulnerability in anti-estrogen response and resistance in invasive lobular carcinoma

2017-07 to 2018-06 | Award
Cancer League of Colorado (CO, CO, US)
GRANT_NUMBER:

173664-MS

Source: Self-asserted source
Matthew J. Sikora

Identifying factors driving estrogen receptor function in invasive lobular carcinoma

2017-01 to 2017-12 | Award
American Cancer Society (GA, GA, US)
GRANT_NUMBER:

25M5073
Source: Self-asserted source
Matthew J. Sikora

WNT4 IN ENDOCRINE RESPONSE AND RESISTANCE IN INVASIVE LOBULAR CARCINOMA

2016-12-07 to 2019-11-30 | Grant
National Cancer Institute (Rockville, US)
URL: https://app.dimensions.ai/details/grant/grant.6501352
GRANT_NUMBER: R00CA193734
Source: Self-asserted source
Matthew J. Sikora via DimensionsWizard

2015 Hormone-Dependent Cancers Gordon Research Conference and Gordon Research Seminar

Source: Self-asserted source
Matthew J. Sikora via DimensionsWizard

Elucidating the function of WNT4 in endocrine response and resistance in invasive lobular carcinoma

Source: Self-asserted source
Matthew J. Sikora via DimensionsWizard

HDAC7 in Tumor Aggressiveness and Resistance to Endocrine Therapy

2012-03-01 to 2015-02-28 | Grant
Congressionally Directed Medical Research Programs (Fort Detrick, US)
URL: https://grants.uberresearch.com/100000090/W81XWH1210063/HDAC7-in-Tumor-Aggressiveness-and-Resistance-to-Endocrine-Therapy
GRANT_NUMBER:

W81XWH1210063
Source: Self-asserted source
Matthew J. Sikora via DimensionsWizard

Peer review (119 reviews for 31 publications/grants)

Review activity for Breast cancer research (41)
Review activity for Breast cancer research and treatment. (8)
Review activity for Breast cancer. (1)
Review activity for Cancer letters. (1)
Review activity for Cancer research. (5)
Review activity for Cell biology and toxicology. (2)
Review activity for Cellular oncology. (1)
Review activity for Cellular oncology. (2)
Review activity for Clinical cancer research. (1)
Review activity for EMBO molecular medicine. (1)
Review activity for Endocrine-related cancer. (3)
Review activity for Endocrinology (1)
Review activity for Endocrinology. (3)
Review activity for Essays in biochemistry. (2)
Review activity for Genes and immunity (2)
Review activity for Genome research. (2)
Review activity for Hormones & cancer (1)
Review activity for International journal of cancer. (3)
Review activity for Journal of the Endocrine Society. (1)
Review activity for Molecular and cellular endocrinology. (5)
Review activity for Molecular cancer research. (7)
Review activity for Molecular cancer therapeutics. (2)
Review activity for Nature communications (3)
Review activity for Neoplasia. (1)
Review activity for NPJ breast cancer. (5)
Review activity for Oncogene. (7)
Review activity for Oncotarget. (1)
Review activity for PeerJ. (1)
Review activity for Science translational medicine. (1)
Review activity for Scientific reports. (4)
Review activity for Seminars in cancer biology. (1)
How many people are using ORCID?